ASX Announcements
Notification regarding unquoted securities - MVF
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities)
- Dec 4, 2024
- 6 pages
November 2024
Monash University’s new boss says don’t call us elite
Despite coming in third overall in The Australian Financial Review’s Best Universities Ranking, it has long had a chip on its shoulder about rival Melbourne.
- Patrick Durkin
January 2024
AI’s processing muscle could help end the ‘torture’ of IVF
Advocates say artificial intelligence can make the IVF process quicker and cheaper by sifting through huge amounts of data in short order. Not everyone agrees.
- Tess Bennett
July 2022
Monash IVF looks lonely as PE seizes control of rivals
Monash IVF could be the sole non-private equity owned operator of scale in its sector by the end of this month.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
February 2022
Virtus Health bids put Monash IVF in spotlight
As two private equity suitors battle for Australia’s biggest fertility services group Virtus Health, analysts are turning their attention to No.2 player Monash IVF.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
January 2022
Monash IVF tipped to become next PE takeover target
Things are about to get interesting in the local IVF market, and it’s not just because of the Virtus M&A battle.
- Yolanda Redrup
December 2021
The stocks poised to declare buybacks in 2022
Allan Gray’s Suhas Nayak on why 2022 could be a year of share buybacks, how Origin sold its interest in APLNG too cheaply, and his wariness around floats.
- Alex Gluyas
November 2021
Health stocks to watch as pandemic eases
Pacific Smiles, NIB and Monash IVF are among the companies favoured by fund managers.
- Tony Featherstone
July 2021
Monash IVF, Virtus get a COVID-19 bump
Monash IVF and Virtus Health are set to benefit from a sharp increase in IVF volumes, according to an analysis of the sector by Macquarie.
- William McInnes
January 2021
Healthcare outlook rests on vaccine rollout
Many healthcare companies were seriously disrupted while dealing with the fallout from COVID-19. As vaccines get rolled out, momentum is likely to return.
- Carrie LaFrenz
December 2020
Monash IVF hit with class action after embryo destruction
A 43-year-old Canberra woman who had her final embryo destroyed by the ASX-listed provider is the lead plaintiff in the action that centres on dud technology.
November 2020
ASX slips 0.7pc in biggest fall this month
The Australian sharemarket snapped a three day winning streak as banks and miners weighed on the index. Bega acquired Lion for $560 million. Stockland appointed Tarun Gupta as its new CEO. Origin raised its gas production outlook.
- Updated
- Robert Guy, Sarah Turner, William McInnes, Tom Richardson and Luke Housego
April 2020
Monash IVF asks investors for a second chance
There's fresh life and fresh hope for beaten-up Monash IVF, which is considering making the most of COVID-19 restrictions being relaxed from this week.
- Sarah Thompson, Anthony Macdonald and Tim Boyd
March 2020
Monash IVF expects patients to defer treatment amid pandemic
Fertility Society of Australia says those planning to start fertility treatment should consult their specialist and discuss the option of postponing it.
- Carrie LaFrenz
Ramsay in talks with government over elective surgery overflow
Anecdotal feedback suggests that elderly patients are deferring semi-elective and elective procedures due to concerns about COVID-19.
- Carrie LaFrenz
January 2019
Chinese billionaire Liu Zaiwang seeks medical help to revive building empire
Construction tycoon Liu Zaiwang has his sights set on the Aussie healthcare sector - especially Healius - to offset China's slowing property market.
- Michael Smith
December 2018
Primary's mate Jangho pops up at Monash IVF
It's more then one year since the takeover sirens started sounding at Monash IVF and the board called investment bank Macquarie Capital to ready the defences.
- Sarah Thompson and Anthony Macdonald
September 2018
Why Lynn Burmeister, Monash IVF's busiest doctor, walked
"It became untenable, it became a situation I couldn't work in," Lynn Burmeister said of her exit from Monash IVF.
- Updated
- Jemima Whyte
February 2018
Boosting IVF success rates behind City Fertility, CHA Healthcare deal
The nation's fourth-biggest IVF company has experienced a 30 per cent jump in inquiries from gay couples since same-sex marriage was legalised.
- Updated
- Julie-anne Sprague
October 2017
Monash IVF, Virtus Health shares flounder
With one in six couples struggling with fertility issues, why aren't the share IVF providers performing better?
- Jessica Sier
July 2017
Monash IVF settles restraint case with Dr Lynn Burmeister
The listed IVF company has settled its restraint case with prominent doctor Dr Lynn Burmeister, who agreed to a one year restraint.
- Updated
- Misa Han